4.2 Article

Use of a new immunoassay to measure PrPSc levels in scrapie-infected sheep brains reveals PrP genotype-specific differences

Journal

JOURNAL OF IMMUNOLOGICAL METHODS
Volume 298, Issue 1-2, Pages 119-128

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jim.2005.01.012

Keywords

scrapie; prion protein (PrP); CDI (conformation-dependent immunoassay); PrP genotype

Ask authors/readers for more resources

The diagnosis of prion diseases, such as scrapie and BSE, has traditionally relied upon the identification of the disease-associated form of the prion protein, PrPSc, based on its resistance to digestion by protemase K (PK). A more recent development is the conformation-dependent immunoassay (CDI), which distinguishes between PrPSc and normal PrP (PrPC) based on their differing solubility in guanidine hydrochloride rather than resistance or sensitivity to PK. We have developed a M-formatted sandwich immunoassay for the measurement of PrPSc in sheep brain, which discriminates between clinically affected scrapie cases (natural or experimental) and uninfected controls of the same PrP genotype. Using this method, we have shown for the first time that, in sheep, the PrP genotype has a significant influence on the amount of PrPSc deposited in the brains of animals experimentally infected with scrapie. (c) 2005 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available